Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH).

CONCLUSION: Systemic and CSF CCL5 levels were elevated after aSAH and levels of serum CCL5 on day 7 were associated independently with clinical outcome (GOS and mRS) at discharge. Therapeutic approaches targeting CCL5 might be beneficial in aSAH. PMID: 32485621 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32485621?dopt=Abstract

Source: Cytokine - May 29, 2020 Category: Molecular Biology Authors: Chaudhry SR, Kinfe TM, Lamprecht A, Niemelä M, Dobreva G, Hänggi D, Muhammad S Tags: Cytokine Source Type: research